Salvus Wealth Management LLC Has $422,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Salvus Wealth Management LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 21.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 835 shares of the healthcare conglomerate’s stock after selling 234 shares during the period. Salvus Wealth Management LLC’s holdings in UnitedHealth Group were worth $422,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new position in UnitedHealth Group during the third quarter worth $32,000. Quarry LP grew its holdings in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH stock opened at $511.02 on Friday. The business has a 50 day moving average of $553.38 and a 200-day moving average of $562.98. The firm has a market cap of $470.28 billion, a PE ratio of 33.29, a P/E/G ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the business posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.